Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Business
Amorfix Life Sciences Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Amorfix Life Sciences Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new market report released


Print article Print article
© companiesandmarkets.com

companiesandmarkets.com
companiesandmarkets.com
2010-03-11 08:13:04 - Amorfix Life Sciences Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - a new market research report on companiesandmarkets.com

www.companiesandmarkets.com/Summary-Company-Profile/amorfix-life ..

Amorfix Life Sciences Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile is an essential source for company data and information. The profile examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the company’s major recent financial deals.

Amorfix Life Sciences Ltd. (Amorfix) is a theranostics company engaged in developing therapeutic products and diagnostic devices for treatment of brain-wasting diseases such as Amyotrophic Lateral Sclerosis (ALS), Alzheimer’s disease, Parkinson’s disease and variant Creutzfeldt - Jakob disease (vCJD). The company intends to develop diagnostic kits, biologic therapeutics, drug therapeutics, and prophylactics, such as vaccines for the treatment of aggregated misfolded proteins (AMP). The company’s

 

 

lead programs include a diagnostic blood screening test for vCJD and a therapy for ALS. The company is headquartered at Mississauga in Ontario, Canada.

And More inside the report…

Recent Developments

Jan 06, 2010: Amorfix Names Robert Gundel As Vice President Of R&D

Scope

- Provides key company information for business intelligence needs
- Gives information on the company’s major recent financial deals including mergers & acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings, partnerships and licensing agreements.
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.

Reasons to buy

- A quick "one-stop-shop" to understand the company.
- Support sales activities by understanding your customers’ businesses.
- Qualify prospective partners and suppliers.
- Understand and respond to your competitors’ business structure, strategy and prospects through.
- Understanding the key deals which have shaped the company.


Author:
Mike King
e-mail
Web: www.companiesandmarkets.com
Phone: London: +44 (0) 203 086 8600

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com | BidVertiser